Article Data

  • Views 211
  • Dowloads 123

Reviews

Open Access

Possibilities and limitation of endoscopic procedures in oncological gynaecology

  • J. Stelmachow1,*,
  • B. Spiewankiewicz1

1Department of Obstetrics and Gynaecology, II Faculty of Medicine The Medical University of Warsaw in Warsaw, Poland

DOI: 10.12892/ejgo20050121 Vol.26,Issue 1,January 2005 pp.21-23

Published: 10 January 2005

*Corresponding Author(s): J. Stelmachow E-mail:

Abstract

In cases of gynaecological cancer, the use of endoscopic techniques, in spite of becoming more frequent, is very controversial. Mainly, the potential risk of dissemination, which worsens the patient prognosis and leads to consequent adjuvant therapy is of concern. Based on data from the literature the authors present the advantages and disadvantages of using hysteroscopy in patients suffering from endometrial malignancy. According to the references and personal experience, the diagnostic and therapeutic value of laparoscopy in cases of cervical, endometrial and ovarian cancer are discussed.

Keywords

Gynaecological oncology; Laparoscopy; Hysteroscopy

Cite and Share

J. Stelmachow,B. Spiewankiewicz. Possibilities and limitation of endoscopic procedures in oncological gynaecology. European Journal of Gynaecological Oncology. 2005. 26(1);21-23.

References

[1] Obermair A.: "Does hysteroscopy facilitate tumor cell dissemination?". Cancer, 2000, 88, 139.

[2] Wang P.H., Yuan C.C., Lin G., Ng H.T., Chao H.T.: "Risk factors contributing to early occurrence of port site metastases of laparoscopic surgery for malignancy". Gynecol. Oncol., 1999, 72, 38.

[3] Childers J.M., Aqua K.A., Survit E.A., Hallum A.V. et al.: "Abdominal-wall tumor implantation after laparoscopy for malignant condition" Obstet. Gynecol., 1994, 84, 765.

[4] Van Dam P.A., DeCloedt J., Tjama W.A., Buytaert P. et al.: "Trocar implantation metastases after laparoscopy in patients with advanced ovarian cancer: Can the risk be reduced". Am. J. Obstet. Gynecol., 1999, 181, 536.

[5] Creasman W.T., Lukeman J.: "Role of fallopian tube in dissemination of malignant cells in corpus cancer". Cancer, 1972,29,456.

[6] Stelmach6w J.: "The role of hysteroscopy in gynecologic oncology". Gynecol. Oncol., 1982, 14, 392.

[7] Bartosik D., Jacobs S.L., Kelly J.: "Endometrial tissue in peritoneal fluid". Fertil. Steril., 1986, 46, 796.

[8] Egarter Ch., Krestan Ch., Kurz Ch.: "Abdominal dissemination of malignant cells with hysteroscopy". Gynecol. Oncol., 1996, 63, 143.

[9] Hirai Y., Takeshima N., Kato T.A., Hasumi K.: "Malignant potential of positive peritoneal cytology in endometrial cancer". Obstet. Gynecol., 2001, 97, 725.

[10] Grimshaw R.N., Tupper W.C., F raser R.C., Tompkins M.G., Jeffrey J.F.: "P rognostic value of peritoneal cytology in endometrial carcinoma". Gynecol. Oncol., 1990, 36, 97.

[11] Theodoridis T.D., Bonyis J.N.: "Laparoscopy and oncology". Ann. N. Y. Acad. Sci., 2003, 997, 282.

[12] Ott D.E.: "The peritoneum and pneumoperitoneum: A review to improve clinical outcome". Gynecol. Surg., 2004, 1, 101

[13] Chen T.R.: "Re-evaluation of HeLa, HeLa S3 and Hep-2 karyotypes". Cytogenet. Cell Genet., 1988, 48, 19.

[14] Watson D.I., Mathew G., Ellis T.: "G asless laparoscopy may reduce the risk of port-site metastases following laparoscopic tumor surgery". Arch. Surg., 1997, 72, 38.

[15] Neuhaus S.J., Watson D.I., Ellis T.: "Efficacy of cytotoxic agents for the prevention of laparoscopic port-site metastases". Arch. Surg., 1998, 133, 762.

[16] Van Dam P.A., DeCloedt J., Tjama W.A., Buytaert P. et al.: "Trocar implantation metastases after laparoscopy in patients with advanced ovarian cancer: Can the risk be reduced". Am. J. Obstet. Gynecol., 1999, 181, 536.

[17] Lehber R., Wenzel R., Heinzl H., Husslein P. et al.: "Influence of delayed staging laparotomy after laparoscopic removal ovarian masses later found malignant". Obstet. Gynecol., 1988, 92, 967.

[18] Kruitwagen R.F., Swinkles B.M., Keyser K.G., Doesburg W.H. et al.: "I ncidence and effect on survival of abdominal wall metastases at trocar puncture sites following laparoscopy or paracentesis in women with ovarian cancer". Gynecol. Oncol., 1996, 60, 233.

[19] Tjama W.A.: "Spread of ovarian cancer after laparoscopic surgery". Gynecol. Oncol., 2000, 78, 77.

[20] Miralles R.M., Petit J., Gine L. et al.: "Metastatic cancer spread at the laparoscopic puncture site. Report of a case in a patient with carcmoma of the ovary. Case report". Eur. J. Gynecol. Oncol., 1989, 169, 522.

[21] Gleeson N.C., Nicosia S.V., Mark J.E.: "Abdominal wall metastases from ovarian cancer after laparoscopy". Am. J. Obstet. Gynecol., 1993, 169, 522.

[22] Onnis A., Marchetti M., Padovan P., Castellan L.: "Neoadjuvant chemotherapy in advanced ovarian cancer". Eur. J. Gynaecol. Oncol., 1996, 17, 393,

[23] Magrina J.F., Weaver A.L.: "Laparoscopic treatment of endometrial cancer:five year reccurence and survival rates". Eur. J. Gynaecol. Oncol., 2004, 25, 439.

[24] Muntz H.G., Golff B.A., Medsen B.L., York J.L.: "Port-site recurrences after laparoscopic surgery of endometrial carcinoma. Obstet. Gynecol., 1999, 93, 807.

[25] Wang P.H., Ming-Skyen Y., Chiau-Chung C.H.: "Port-site metastasis after laparoscopic assisted vaginal hysterectomy for endometrial cancer Mechanism and prevention". Gynecol. Oncol., 1997, 66, 151.

[26] Sonoda Y., Zerbe M., Smith A., Lin 0., Barakat R.R., Hoskins W.J.: "High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy". Gynecol. Oncol., 2002, 84, 537.

[27] He Y.L., Zhang L.Y., Lu J.R., Pan S.L., Yang J., Chen Y.Y. et al.: "Laparoscopic radical hysterectomy and pelvic lymphadenectomy: analysis of 14 cases". Di Yi Jun Yi Da Xue Xue Bao., 2002, 22, 1136.

[28] Posser M.: "Options for laparoscopic surgery in cervical carcinomas". Eur. J. Gynecol. Oncol., 2003, 24, 471.

[29] Staging classifications and clinical practice guidelines of gynecologic cancers by F IGO Committee on Gynecologic Oncology and IGCS Guideline Committee. JL Benedet, NF Hacker, HYS Ngan (eds.). Santiago de Chile, Elsevier 2003, 43.

[30] Schlaerth J.B., Spirtos N.M., Carson L.F.: "Laparoscopic retroperitoneal lymphadenectomy followed by immidiete laparotomy in women with cervical cancer;a Gynecologic Oncology Group". Gynecol. Oncol., 2002, 85, 81.

[31] Ayhan A., Celik H., Dursun P., Gultekin M., Yuce K.: "Prognostic and therapeutic importance of lymphadenectomy in gynecological cancers" Eur. J. Gynaecol. Oncol., 2004, 25, 279.

[32] Cohn D.E., Tamini H.K., Golf B.A.: "Intraperitoneal spred of cervical carcinoma after laparoscopic lymphadenectomy". Obstet. Gynecol., 1997, 89, 864,

[33] Nauman R.W., Spencer S.: "An umbilical metastasis after laparoscopy for squamous cell carcinoma of cervix". Gynecol. Oncol., 1997, 64, 507.

[34] Pastner B., Damien M.: "Umbilical metastases from a Stage IB cervical cancer after laparoscopy: A case report". Fertil. Steril., 1992, 58, 1248.

[35] Tjama W.A., Winter-Roach B.A., Rowlands P., de Barros, Lopes A.: "Port-site recurrence following laparoscopic surgery in cervical cancer" Int. J. Gynecol. Cancer, 2001, 11, 409.

[36] Cravalho J.P., Souen J., Pinotti J.A.:'Trocar site metastasis after laparoscopic pelvic lymphadenectomy for cervical sqamosus cell carcinoma". In. J. Gynecol. Obstet., 1999, 67, 111.

[37] Agostini A., Cohen D., Cravello L., Bretelle F., Roger V., Blanc B.: "Port-site recurrences following laparoscopic para-aortic lymphadenectomy for squamous carcinoma of cervix". Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 98, 258.

[38] Gregor H., Sam Ch. E., Reinthaller A., Jourta E.A.: "Port-site metastases after laparoscopic lymph node staging of cervical carcinoma". J. Am Assoc. Gynecol. Laparosc., 2001, 8, 591.

[39] Lavie O., Cross P.A., Beller U., Dawlatly B., Lopes A., Monaghan J.M.: "Laparo、copic port-site metastasis of an early stage adenocarcmoma of cervix with negative lymph nodes". Gynecol. Oncol., 1999, 75, 155.

[40] Kohlbergher P.O., Edwards L., Collins C., Milross C., Hacker N.F.: "Laparoscopic port-site recurrence following surgery for stage lb sqamosus cell carcinoma of the cervix with negative lymph nodes". Gynecol. Oncol., 2000, 79, 324.

[41] Kadar N.: "Port-site recurrences following laparoscopic operations for gynecological malignances". Br. J. Obstet. Gynecol., 1997, 104, 1308.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top